Approvals in Hand, Lilly and Novo Obesity Pills Will Battle It Out on Hairline Differences

April 2, 2026

BioSpace

After Eli Lilly achieved the milestone approval of the weight loss pill Foundayo, Novo Nordisk launched a full-court press to defend oral Wegovy, which has been enjoying a record-breaking launch since